Clinical trials recruiting for Renal Cell Cancer
7
Recruiting trials
10
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Aldesleukin | 1 |
| Alintegimod | 1 |
| Anti-hCD70 CAR transduced PBL | 1 |
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| IBI363 | 1 |
| Ipilimumab | 1 |
| Modi-1 Moditope | 1 |
| Nivolumab | 1 |
| Pembrolizumab | 1 |
| TT-10 | 1 |
| TT-4 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| California | 2 |
| Florida | 2 |
| Colorado | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Michigan | 1 |
| New Hampshire | 1 |
| Rhode Island | 1 |
| Washington | 1 |
Top cities
Houston, Texas 3Aurora, Colorado 1Bethesda, Maryland 1Dearborn, Michigan 1Fairway, Kansas 1Lake Mary, Florida 1Lebanon, New Hampshire 1Los Angeles, California 1Ocala, Florida 1Plantation, Florida 1
Self-screener
Recruiting trials
- A Study of IBI363 in Subjects with Advanced Solid Malignancies
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
- Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
- Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
- TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Related conditions
Trials recruiting for Renal Cell Cancer often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Non-small cell lung cancer 507Melanoma 487Lung cancer 2180Colorectal cancer 1359Ureter Cancer 3Ovarian cancer 118Breast cancer 2239Bladder cancer 59Triple-negative breast cancer 138
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Renal Cell Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.